On Tuesday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was 59.59% up from the session before settling in for the closing price of $1.80. A 52-week range for SXTP has been $1.41 – $35.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 43.88% over the last five years. When this article was written, the company’s average yearly earnings per share was at 81.77%. With a float of $1.38 million, this company’s outstanding shares have now reached $1.47 million.
The firm has a total of 3 workers. Let’s measure their productivity. In terms of profitability, gross margin is 39.69%, operating margin of -1522.88%, and the pretax margin is -1247.06%.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward 60 Degrees Pharmaceuticals Inc stocks. The insider ownership of 60 Degrees Pharmaceuticals Inc is 6.27%, while institutional ownership is 2.08%. The most recent insider transaction that took place on Dec 13 ’24, was worth 9,375. In this transaction Director of this company bought 6,000 shares at a rate of $1.56, taking the stock ownership to the 52,078 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Director bought 5,000 for $1.82, making the entire transaction worth $9,125. This insider now owns 46,078 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 71.59% during the next five years compared to 12.29% growth over the previous five years of trading.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
You can see what 60 Degrees Pharmaceuticals Inc (SXTP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -27.07, a number that is poised to hit -1.31 in the next quarter and is forecasted to reach -3.23 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
Analysing the last 5-days average volume posted by the [60 Degrees Pharmaceuticals Inc, SXTP], we can find that recorded value of 17.06 million was better than the volume posted last year of 1.72 million. As of the previous 9 days, the stock’s Stochastic %D was 43.82%. Additionally, its Average True Range was 0.39.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 13.22%, which indicates a significant decrease from 45.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 201.71% in the past 14 days, which was higher than the 173.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3100, while its 200-day Moving Average is $6.1900. Now, the first resistance to watch is $4.0700. This is followed by the second major resistance level at $5.2700. The third major resistance level sits at $6.1300. If the price goes on to break the first support level at $2.0100, it is likely to go to the next support level at $1.1500.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are 1,473K outstanding shares of the company, which has a market capitalization of 4.23 million. As of now, sales total 680 K while income totals -7,950 K. Its latest quarter income was 260 K while its last quarter net income were -2,050 K.
